UID No. : 202502956 C.No.

: 8 Registration Date : 13-Mar-2025 4:20PM

Patient Name : Mr. NITESH Collection Time : 13-Mar-2025 4:20PM
Age/ Gender : 25Y / Male Reporting Time : 13-Mar-2025 7:22PM
Referred By : Dr. DR. SALMAN Printing Time : 13-Mar-2025 7:29PM
Sample Type : EDTA Sample Barcode :

Test Name Results Units Biological Ref-Interval

HAEMATOLOGY
COMPLETE BLOOD COUNT
HAEMOGLOBIN 14.80 gm/dl 13.0-17.0
(Colorimetry)

TOTAL LEUCOCYTE COUNT 7.65 Thousand/Cumm 4.0-10.0

(Electric Impedence)

DIFFERENTIAL LEUCOCYTE COUNT

(Microscopy)

Neutrophils 74.0 %. 40-75

Lymphocytes 22.0 %. 20-45

Eosinophils 02.0 %. 1-6

Monocytes 02.0 %. 1-8

Basophils 00.0 %. 0-0

Immature Cells 00.0 % 0-0

TOTAL R.B.C. COUNT 4.98 Million/Cumm 4.5-5.5

(Electric Impedence)

Haematocrit Value (P.C.V.) 42.00 % 40-50

(Calculated)

MCV 84.34 fL 76-98

(Calculated)

MCH 29.72 pg 27-32

(Calculated)

MCHC 35.24 H g/dl 31-35

(Calculated)

RDW-SD 38.00 fL 35.0-56.0

(Calculated)

Platelet Count 412 Thousand/Cumm 150-450

(Electric Impedence)

PDW 10.24 % 9.6-15.2

Dr. Renu Singh Dr. Vimla Maurya

MBBS MD (Pathologist) MD (Pathologist)

Developed by: www.saralpath.com Page 1 of 8

 UID No. : 202502956 C.No.: 8 Registration Date : 13-Mar-2025 4:20PM
Patient Name : Mr. NITESH Collection Time : 13-Mar-2025 4:20PM
Age/ Gender : 25Y / Male Reporting Time : 13-Mar-2025 7:22PM
Referred By : Dr. DR. SALMAN Printing Time : 13-Mar-2025 7:29PM
Sample Type : EDTA Sample Barcode :

Test Name Results Units Biological Ref-Interval

Erythrocyte Sedimentation Rate

(Modified Westergren)

At the end of 1st hour 06 mm 0-10

Dr. Renu Singh Dr. Vimla Maurya

MBBS MD (Pathologist) MD (Pathologist)

Developed by: www.saralpath.com Page 2 of 8

 UID No. : 202502956 C.No.: 8 Registration Date : 13-Mar-2025 4:20PM
Patient Name : Mr. NITESH Collection Time : 13-Mar-2025 4:20PM
Age/ Gender : 25Y / Male Reporting Time : 13-Mar-2025 7:22PM
Referred By : Dr. DR. SALMAN Printing Time : 13-Mar-2025 7:29PM
Sample Type : CITRATE Sample Barcode :

Test Name Results Units Biological Ref-Interval

PROTHROMBIN TIME (PT)

Patient 15.1 Seconds
Control 13.0 Seconds 13.0

International Ratio (INR) 1.16 RATIO

NOTE: 1.INR is the parameter of choice in monitoring adequacy of oral anticoagulant therapy.Appropriate therapeutic
range varies with disease and treatment intensity.
2.Prolonged INR suggests potential bleeding disorder/bleeding complications.
3.Results should be clinically correlated.
4.Test conducted on Citrated plasma.
Recommended Therapeutic range for Oral Anticoagulant therapy
INR 2.0-3.0
* Treatment of Venous thrombosis and pulmoonary embolism
* Prophylaxis of Venous thrombosis (High risk surgery)
* Prevention of systemic embolism in tissue heart valves,AMI, Valvular heart disease & Atrial
fibrillation
* Bileaflet mechanical valve in aortic position.
INR 2.5-3.5 :
* Mechanical prosthetic valves
* Systemic recurrent emboli
Comments: Prothrombin time measures the extrinsic coagulation pathway which consists of activated factor VII (VIIa),
Tissue factor and proteins of the common pathway (Factors X , V , II & Fibrinogen).This assay is used to
control long term oral anticoagulant therapy, evaluation of liver function & to evaluate coagulation disorders specially
factors involved in the extrinsic pathway like factors V, VII , X , Prothrombin & Fibrinogen.

Dr. Renu Singh Dr. Vimla Maurya

MBBS MD (Pathologist) MD (Pathologist)

Developed by: www.saralpath.com Page 3 of 8

 UID No. : 202502956 C.No.: 8 Registration Date : 13-Mar-2025 4:20PM
Patient Name : Mr. NITESH Collection Time : 13-Mar-2025 4:20PM
Age/ Gender : 25Y / Male Reporting Time : 13-Mar-2025 7:24PM
Referred By : Dr. DR. SALMAN Printing Time : 13-Mar-2025 7:29PM
Sample Type : SERUM Sample Barcode :

Test Name Results Units Biological Ref-Interval

BIOCHEMISTRY
BLOOD SUGAR RANDOM 121.0 mg/dl 80 - 150

The blood gluose test may be used to detect high bloo glucose (hyperglycemia) and low blood glucose (hyperglycemia) and to screen
for diabetes in people who are at risk before signs and symptoms are apparent; in some cases , there may be no early signs or
symptoms of diabetes.

Dr. Renu Singh Dr. Vimla Maurya

MBBS MD (Pathologist) MD (Pathologist)

Developed by: www.saralpath.com Page 4 of 8

 UID No. : 202502956 C.No.: 8 Registration Date : 13-Mar-2025 4:20PM
Patient Name : Mr. NITESH Collection Time : 13-Mar-2025 4:20PM
Age/ Gender : 25Y / Male Reporting Time : 13-Mar-2025 7:24PM
Referred By : Dr. DR. SALMAN Printing Time : 13-Mar-2025 7:29PM
Sample Type : SERUM Sample Barcode :

Test Name Results Units Biological Ref-Interval

LIVER PROFILE TEST

BILIRUBIN TOTAL 0.78 mg/dl 0.2 - 1.2
Methodology :Diazonium Ion Blanked

BILIRUBIN DIRECT 0.24 mg/dl 0.0-0.4

Methodology :DUD

BILIRUBIN INDIRECT 0.54 mg/dl 0.4 - 1.0

Methodology : Calculated

S.G.O.T. 24.0 U/L 0 - 45

Methodology : UV without P5P

S.G.P.T. 29.0 U/L 0 - 49

Methodology : UV without P5P

SERUM ALKALINE PHOSPHATASE 128.00 IU/L 40.0-140.0

SERUM PROTEINS
TOTAL PROTEINS 7.89 Gm/dL. 6.0 - 8.3
Methodology : Biuret

ALBUMIN 5.01 Gm/dL. 3.5 - 5.5

Methodology : BCG

GLOBULIN 2.88 Gm/dL. 2.3 - 3.5

Methodology : Calculated

A : G RATIO 1.74 0.0 - 2.0

Methodology : Calculated
LIVER FUNCTION TESTS CHECK THE LEVEL OF CERTAIN ENZYMES AND PROTEINS IN BLOOD
Levels that are higher or lower than normal can indicate liver problems. Some common liver function tests include :
Alanine transaminase (ALT). ALT is an enzyme found in the liver and When the liver is damaged,ALT is released into the bloodstream and levels
increase.
Aspartate transaminase (AST). AST is an enzyme that helps metabolize alanine,an amino acid.AST is normally present in blood at low levels. An
increase in AST levels may indicate liver damage or disease or muscle damage.
Alkaline phosphatase (ALP). ALP is an enzyme in the liver, bile ducts and bone.

Dr. Renu Singh Dr. Vimla Maurya

MBBS MD (Pathologist) MD (Pathologist)

Developed by: www.saralpath.com Page 5 of 8

 UID No. : 202502956 C.No.: 8 Registration Date : 13-Mar-2025 4:20PM
Patient Name : Mr. NITESH Collection Time : 13-Mar-2025 4:20PM
Age/ Gender : 25Y / Male Reporting Time : 13-Mar-2025 7:24PM
Referred By : Dr. DR. SALMAN Printing Time : 13-Mar-2025 7:29PM
Sample Type : SERUM Sample Barcode :

Test Name Results Units Biological Ref-Interval

KIDNEY FUNCTION TEST

BLOOD UREA 31.00 mg/dl 13-45
Methodology : Urease UV

SERUM CREATININE 1.00 mg/dl 0.6-1.4

Methodology : Enzymatic method

SERUM URIC ACID 4.75 mg/dl 2.5 - 6.6

Methodology : Colorimetric

SERUM SODIUM (Na) 141.00 mmol/l 135 - 150

Methodology : ISE

SERUM POTASSIUM (K) 4.05 mmol/l 3.5 - 5.5

Methodology : ISE

CALCIUM 9.30 mg/dl 8.5-11

Methodology : ISE
INTERPRETATION:
Urea is the end product of protein metabolism. It reflects on funcioning of the kidney in the body. Creatinine is the end product of
creatine metabolism. It is a measure of renal function and eleveted levels are observed in patients typically with 50% or greater
impairment of renal function. Sodium is critical in maintaining water & osmotic concentrations . Potassium is an essential element
involved in critical cell functions. Potassium levels are influenced by electrolyte intake ,excretion and other means of elemination,
exercise, hydration and medications. Calcium imbalance my cause a spectrum of disease . High concentrations are seen in
Hyperparathyroidism, Malignancy & Sarcoidosis.
Low levels may be due to protein deficiency, renal insufficiency and Hypoparathyroidism. Repeat measurement is recommended if the
values are outside the reference range.

Dr. Renu Singh Dr. Vimla Maurya

MBBS MD (Pathologist) MD (Pathologist)

Developed by: www.saralpath.com Page 6 of 8

 UID No. : 202502956 C.No.: 8 Registration Date : 13-Mar-2025 4:20PM
Patient Name : Mr. NITESH Collection Time : 13-Mar-2025 4:20PM
Age/ Gender : 25Y / Male Reporting Time : 13-Mar-2025 7:24PM
Referred By : Dr. DR. SALMAN Printing Time : 13-Mar-2025 7:29PM
Sample Type : SERUM Sample Barcode :

Test Name Results Units Biological Ref-Interval

SEROLOGY
C-REACTIVE PROTEIN(QUANTITATIVE 4.28 mg/l 0.0 - 6.0

C-reactive protein (CRP) is serum protein synthesized in the liver. CRP level increases within hours of an acute in injury or the onset
of inflammation in conditions like septicemia, meningitis, inflammatory disorders,post surgery or myocardial infarction. It is a semi
quantitative test based on the principle agglutination.
HEPATITIS C VIRUS
HCV NON REACTIVE NON-REACTIVE

Comments:
1- This is only a screening test. All reactive samples must be confirmed by RIBA.
2-A Non-reactive result does not exclude the possibility of exposure to or infection with HCV.
3- The presence of anti-HCV does not imply Hepatitis C infection but may be indicatiive of recent
and/or past HCV infection.
4- False reactive result may occur in patients with auto-immune liver discases, renal disorders and
antenatal samples

HIV (1 & 2)
HIV 1 NON REACTIVE NON REACTIVE

HIV 2 NON REACTIVE NON REACTIVE

COMMENTS:
1. This is only a screening test . All reactive samples must be confirmed by using HIV Western Blot or
ELISA.
2. Non reactive result may occur in "window priod".
3. False positive reaction may occur in some bacterial , Viral infections , passive immunization, renal
dissorders, malignant neoplasms, rheumatoid arthritis, HLA antibodies etc.
4. The sensitivity and specificity of this test has been determined by National HIV Reference Centares
of Govt. of India and WHO Collaborating center , using various other test panels.

Dr. Renu Singh Dr. Vimla Maurya

MBBS MD (Pathologist) MD (Pathologist)

Developed by: www.saralpath.com Page 7 of 8

 UID No. : 202502956 C.No.: 8 Registration Date : 13-Mar-2025 4:20PM
Patient Name : Mr. NITESH Collection Time : 13-Mar-2025 4:20PM
Age/ Gender : 25Y / Male Reporting Time : 13-Mar-2025 7:24PM
Referred By : Dr. DR. SALMAN Printing Time : 13-Mar-2025 7:29PM
Sample Type : SERUM Sample Barcode :

Test Name Results Units Biological Ref-Interval

AUSTRALIA ANTIGEN (HBsAG) NON REACTIVE NON - REACTIVE

Comment: This assay detects the first serological marker of Hepatitis B as early as 4-16 weeks after exposure. It persists during acute illness and disappears 12-20
week after onset of symptoms. The titres during the period of viral replication and is frequently associated with infectivity. Persistence of HBsAg for more than
6months indicates development of carrier state or chronic liver disease. Uses - * Routine screening of blood and blood products to prevent prevent transmission of
Hepatitis B virus (HBS) to recipients * To diagnose suspected HBV infection and monitor the status of infected infected individuals * To evaluate the efficacy of
antiviral drugs * For prenatal Screening of pregnant women False Reactivity may be observed under the following circumstances: * Non repeatable reactives: These
are due to particulate matter particularly fibrin,clots and cellular material in patient * Non specific reactives: All highly sensitive immunoaassay systems have a
potential for nonspecific reactions. This can be eliminated by confirming the result by the Neutralization test

----------{END OF REPORT }----------

Dr. Renu Singh Dr. Vimla Maurya

MBBS MD (Pathologist) MD (Pathologist)

Developed by: www.saralpath.com Page 8 of 8